Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia

Keyphrases

• Benign Prostatic Hyperplasia 100%
• Anticoagulated Patients 100%
• 532 Nm Laser 100%
• Photoselective Vaporization of the Prostate 100%
• Laser Prostatectomy 100%
• High Risk 60%
• Operative Time 40%
• Post-void Residual 40%
• Hematocrit 40%
• Systemic Anticoagulation 40%
• Maximum Flow Rate 40%
• International Prostate Symptom Score 40%
• Anticoagulation 20%
• Warfarin 20%
• Comorbidity 20%
• Heart Failure 20%
• Reoperation 20%
• Bleeding 20%
• High-risk Population 20%
• Prostate-specific Antigen 20%
• Clopidogrel 20%
• Clinical Improvement 20%
• Urinary Tract Infection 20%
• Anticoagulants 20%
• Anticoagulated 20%
• Am(III) 20%
• Blood Transfusion 20%
• Charlson Comorbidity Index 20%
• Incontinence 20%
• American Society of Anesthesiologists 20%
• Acetylsalicylic Acid 20%
• Electrocautery 20%
• Prostate Volume 20%
• Transurethral Resection of Prostate 20%
• Symptomatic Benign Prostatic Hyperplasia 20%
• Intravenous Fluids 20%
• Urethral Stricture 20%
• Serum Sodium 20%
• Energy Use 20%
• Open Prostatectomy 20%
• Anticoagulation Agents 20%
• Mean Energy 20%
• Large Prostate 20%
• Delayed Bleeding 20%

Medicine and Dentistry

• Anticoagulation 100%
• Prostate Hypertrophy 100%
• Laser Prostatectomy 100%
• Residual Urine 66%
• Hematocrit 66%
• International Prostate Symptom Score 66%
• Incontinence 33%
• Prostatectomy 33%
• Urinary Tract Infection 33%
• Congestive Heart Failure 33%
• Anesthesiologist 33%
• Reoperation 33%
• Blood Transfusion 33%
• Fulguration 33%
• Antithrombotic 33%
• Acetylsalicylic Acid 33%
• Clopidogrel 33%
• Prostate Specific Antigen 33%
• Charlson Comorbidity Index 33%
• Warfarin 33%
• Transurethral Resection 33%
• Anticoagulant 33%
• Infusion Fluid 33%
• Urethra Stenosis 33%
• Comorbidity 33%